Menu

Hims & Hers inks deal with Eli Lilly to offer branded weight loss drugs
📰

Hims & Hers inks deal with Eli Lilly to offer branded weight loss drugs

Business - Latest - Google News·8 days ago
#fKmo0y9L
#world#news#fiercehealthcare#hims#hers
Reading 0:00
15s threshold

Hims & Hers struck a deal with Eli Lilly to offer the drugmaker’s branded obesity treatments through its online health and wellness platform.

Under the agreement, Eli Lilly will give Hims & Hers pharmacies direct access to its U.S. Food and Drug Administration-approved GLP-1 medications at self-pay prices. Eligible patients on the Hims & Hers platform can be prescribed and order Eli Lilly's injectable Zepbound (tirzepatide) and daily oral medication Foundayo (orforglipron) without leaving the company's platform.

Prior to this agreement, Lilly drugs were available to patients on Hims & Hers only if they left the site and went to Lilly's direct-to-consumer platform, LillyDirect.

Shares of Hims & Hers jumped 8% Friday following news of the Eli Lilly partnership.

The agreement brings together Lilly’s obesity medicines and Hims & Hers’ consumer platform to expand consumers' access to FDA-approved weight loss drugs, the companies said.

"Patients can complete a consultation, receive a prescription if their…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.